概括
黄患者的癌胚抗原 (CEA) 水平升高通常表明良性胆道阻塞,而不是癌症. CEA水平与肝功能测试相关,并在阻塞缓解后正常化.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
背景情况:
- 癌胚抗原 (CEA) 的升高通常与恶性瘤有关.
- 良性疾病,如胆道阻塞,也会影响CEA水平.
- 了解CEA在良性肝病中的行为对于准确诊断至关重要.
研究的目的:
- 为了研究循环癌胚抗原 (CEA) 水平和肝功能测试在患有良性肝外胆道阻塞的患者之间的关系.
- 为了确定黄患者中CEA水平的升高是否表明恶性或良性疾病.
主要方法:
- 研究了29名患有良性肝外胆道阻塞和炎症的黄患者.
- 测量了循环中的癌胚抗原 (CEA) 水平.
- 评估肝功能测试,包括血清性酸酶和胆红素.
- 在缓解障碍之前和之后监测CEA水平.
主要成果:
- 52%的患者在阻塞期间出现CEA水平升高 (>2.5 ng/ml).
- 升高的CEA在常见的胆道结石和胆管炎中比胆囊结石和胆囊炎更频繁.
- 在CEA升高的患者中,血清性酸酶和胆红素水平显著更高.
- 在阻塞缓解后,70%的患者的CEA水平正常化.
结论:
- 黄患者的循环癌胚抗原 (CEA) 水平升高可能与良性胆道阻塞和炎症有关.
- 这些患者的CEA水平与肝功能测试异常相关.
- 在阻塞性黄的背景下,CEA升高并不一定意味着癌症,这突显了临床背景的重要性.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...


